We are live on
!
Find out more
Parallel Advisors Portfolio holdings
AUM
$6.56B
Turnover
11.49%
1-Year Est. Return
32.24%
This Fund
S&P 500
This Quarter
Est. Return
-0.84%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$2.48B
AUM Growth
+$119M
(+5%)
Cap. Flow
+$158M
Cap. Flow
% of AUM
6.35%
Top 10 Holdings %
Top 10 Hldgs %
35.06%
Holding
3,425
New
363
Increased
1,606
Reduced
626
Closed
190
Avg Time Held Equity + Options
2.6
years
Top 10 Avg Time Held Equity + Options
2
years
Top 20 Avg Time Held Equity + Options
2.1
years
Avg Time Held Equity only
2.6
years
Top 10 Avg Time Held Equity only
2
years
Top 20 Avg Time Held Equity only
2.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$24.8M |
| 2 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$24.7M |
| 3 |
iShares Core US REIT ETF
USRT
|
+$23.7M |
| 4 |
Coupang
CPNG
|
+$22M |
| 5 |
FTOC
FTAC Olympus Acquisition Corp. Class A Ordinary Shares
FTOC
|
+$15.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Medical Devices ETF
IHI
|
+$15.9M |
| 2 |
iShares Global Tech ETF
IXN
|
+$14.7M |
| 3 |
iShares US Treasury Bond ETF
GOVT
|
+$9.94M |
| 4 |
iShares MSCI USA Min Vol Factor ETF
USMV
|
+$3.22M |
| 5 |
Vanguard Morningstar Large-Cap ETF
VV
|
+$2.39M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 51.99% |
| 2 | Technology | 15.91% |
| 3 | Financials | 8.1% |
| 4 | Healthcare | 5.94% |
| 5 | Consumer Discretionary | 5.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2651
Energy Recovery
ERII
$340M
| $2K | ﹤0.01% |
128
-285
| -69% | -$5.79K |
2021 Q1
2 quarters
|
|
2652
DELISTED
Enstar Group
ESGR
| $2K | ﹤0.01% |
9
+3
| +50% | +$732 |
2020 Q1
6 quarters
|
|
2653
DELISTED
Esperion Therapeutics
ESPR
| $2K | ﹤0.01% |
126
+124
| +6,200% | +$1.8K |
2020 Q3
4 quarters
|
|
2654
Eaton Vance Municipal Income 2028 Term Trust
ETX
$188M
| $2K | ﹤0.01% |
89
| – | – |
2020 Q4
3 quarters
|
|
2655
iShares MSCI Brazil ETF
EWZ
$11.6B
| $2K | ﹤0.01% |
60
| – | – |
2021 Q2
1 quarter
|
|
2656
Future Fuel
FF
$247M
| $2K | ﹤0.01% |
+263
| New | +$2.18K |
2021 Q3
0 quarters
|
|
2657
First Financial Bancorp
FFBC
$3.31B
| $2K | ﹤0.01% |
77
| – | – |
2020 Q2
5 quarters
|
|
2658
First Interstate BancSystem
FIBK
$3.32B
| $2K | ﹤0.01% |
+40
| New | +$1.7K |
2021 Q3
0 quarters
|
|
2659
Schwab Fundamental US Small Company Index ETF
FNDA
$8.7B
| $2K | ﹤0.01% |
82
-58
| -41% | -$1.54K |
2018 Q3
12 quarters
|
|
2660
H.B. Fuller
FUL
$2.79B
| $2K | ﹤0.01% |
28
-100
| -78% | -$6.48K |
2021 Q2
1 quarter
|
|
2661
The Greenbrier Companies
GBX
$1.21B
| $2K | ﹤0.01% |
56
| – | – |
2020 Q1
6 quarters
|
|
2662
USA Today Co
TDAY
$1.02B
| $2K | ﹤0.01% |
245
| – | – |
2021 Q2
1 quarter
|
|
2663
Global X Genomics & Biotechnology ETF
GNOM
$96M
| $2K | ﹤0.01% |
24
| – | – |
2021 Q2
1 quarter
|
|
2664
Acushnet Holdings
GOLF
$4.67B
| $2K | ﹤0.01% |
48
+14
| +41% | +$712 |
2021 Q2
1 quarter
|
|
2665
Globalstar
GSAT
$10.7B
| $2K | ﹤0.01% |
+68
| New | +$1.67K |
2021 Q3
0 quarters
|
|
2666
Hudbay
HBM
$10.6B
| $2K | ﹤0.01% |
+362
| New | +$2.29K |
2021 Q3
0 quarters
|
|
2667
Hingham Institution for Saving
HIFS
$645M
| $2K | ﹤0.01% |
5
| – | – |
2020 Q4
3 quarters
|
|
2668
HIVE Digital Technologies
HIVE
$560M
| $2K | ﹤0.01% |
+130
| New | +$1.82K |
2021 Q3
0 quarters
|
|
2669
Heron Therapeutics
HRTX
$69M
| $2K | ﹤0.01% |
200
| – | – |
2020 Q1
6 quarters
|
|
2670
iShares Euro High Yield Corporate Bond USD Hedged ETF
EUHY
$248M
| $2K | ﹤0.01% |
42
| – | – |
2016 Q4
19 quarters
|
|
2671
International Bancshares
IBOC
$4.2B
| $2K | ﹤0.01% |
50
-2
| -4% | -$82 |
2016 Q4
19 quarters
|
|
2672
INmune Bio
INMB
$43.9M
| $2K | ﹤0.01% |
100
| – | – |
2021 Q1
2 quarters
|
|
2673
The Joint Corp
JYNT
$99.1M
| $2K | ﹤0.01% |
21
| – | – |
2021 Q2
1 quarter
|
|
2674
Openlane
OPLN
$4.51B
| $2K | ﹤0.01% |
148
| – | – |
2017 Q1
18 quarters
|
|
2675
Lithia Motors
LAD
$6.47B
| $2K | ﹤0.01% |
7
-16
| -70% | -$5.57K |
2021 Q2
1 quarter
|
|
Similar funds
Parallel Advisors's Q3 2021 Portfolio in Review
As of Q3 2021, Parallel Advisors held 3,425 positions worth $2.48B, up 5% from $2.36B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Parallel Advisors deployed $158M of net new capital in Q3 2021, opening 363 new positions and adding to 1,606 existing holdings. Its largest new stake was iShares ESG Aware 1-5 Year USD Corporate Bond ETF: 13,650 shares worth $355K.
By sector, the portfolio is most concentrated in Miscellaneous at 52% of assets, down from 53% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was iShares US Medical Devices ETF, an estimated $15.9M trimmed.
- Parallel Advisors's largest Q3 2021 buy was iShares ESG Aware 1-5 Year USD Corporate Bond ETF: 13,650 shares worth $355K.
- Parallel Advisors added most to iShares Core MSCI EAFE ETF in Q3 2021, an estimated $24.8M increase.
- Parallel Advisors's biggest Q3 2021 reduction was iShares US Medical Devices ETF, cutting an estimated $15.9M.
- Parallel Advisors fully exited Slack Technologies, Inc. in Q3 2021, selling an estimated $1.71M.
- Parallel Advisors's ten largest holdings make up 35% of its $2.48B portfolio in Q3 2021.
- Parallel Advisors opened 363 new positions and closed 190 in Q3 2021.
- Parallel Advisors's portfolio value rose 5% quarter-over-quarter to $2.48B.
Based on Parallel Advisors's 13F filing for Q3 2021, filed 22 Oct 2021.